In October, the PPAHS celebrated it’s 5th anniversary. In addition to building around the growing body of knowledge regarding accounting for OSA in patients receiving opioids, the PPAHS also announced a new campaign targeting VTE in orthopedic patients. Continue reading “Top 10 Patient Safety Must Reads – October 2016”
Tag: opioid induced respiratory depression
This week from PPAHS we created a two-part article series examining patient monitoring strategies. We also found 2 insightful articles adding to our knowledge of the opioid crisis, and a spotlight on alarm fatigue. Continue reading “Patient Safety Weekly Must Reads – October 14, 2016”
The Physician-Patient Alliance for Health & Safety (PPAHS) will be presenting at the American Conference Institute’s 2nd Annual Advanced Forum on Medical Liability, Claims, Coverage, and Risk Management in New York City. The 2-day conference, running from October 27 to 28, will bring together professionals from government, healthcare, risk management, and legal fields to discuss the latest trends and issues in today’s fast-paced medical liability landscape.
Michael Wong, JD, PPAHS executive director, will convene a panel titled “New Claims Trends Related to the U.S. Pain Crisis: Taking a Look at the Recent Prescription Opioid Abuse Epidemic and Its Impact on a New Wave of Med Mal Insurance Claims”. He will be joined by Linda Van Dillen, CompAlliance Managed Care; Michael D. Anderson, Sr. Claims Examiner & Risk Specialist Medical Insurance Exchange of California, Medical underwriters of California; and Keri Marmorek, Specialty Lines, Beazley USA. The panel will occur on day two of the conference, October 28, 2016. Continue reading “PPAHS to Present at ACI Annual Advanced Forum on Medical Liability, Claims, Coverage, and Risk Management”
As a follow-up to our latest podcast interview with Thomas W. Frederickson, MD, FACP, SFHM, MBA – lead author of the Society of Hospital Medicine RADEO guide (“Reducing Adverse Drug Events Related to Opioids”) – we focused on the advantages and limitations of pulse oximetry in monitoring patients for opioid-induced respiratory depression.
Most importantly, Dr. Frederickson highlighted that the alerts provided by pulse oximetry can be a lagging indicator of patient ventilation, particularly when supplemental oxygen is administered. One solution to improving the care provided to patients is to understand that pulse oximetry is one part of a comprehensive monitoring strategy. Continue reading “3 Keys To Successfully Implementing Capnography”
This week from PPAHS and around the web, we celebrate our 5th anniversary with some sharable tips for improving #patientsafety. We’ve also found 2 great studies and an interesting infographic about the opioid epidemic.
In PPAHS’ latest podcast, we spoke with Thomas W. Frederickson, MD, FACP, SFHM, MBA – lead author of the Society of Hospital Medicine RADEO guide (“Reducing Adverse Drug Events Related to Opioids”). The RADEO guide is a comprehensive clinician manual created with the aim to decrease opioid-related adverse events in an inpatient setting. Continue reading “3 Limitations to the Use of Pulse Oximetry”
As we flip our calendars to October, here’s a roundup of PPAH’s top posts and tweets from last month. Continue reading “Top 10 Patient Safety Must Reads – September 2016”
The Physician-Patient Alliance for Health & Safety (PPAHS) had the pleasure of interviewing Thomas W. Frederickson, MD, FACP, SFHM, MBA – lead author of the Society of Hospital Medicine RADEO guide (“Reducing Adverse Drug Events Related to Opioids”). The guide is a comprehensive clinician manual created with the aim to decrease opioid-related adverse events in an inpatient setting.
In the first of this two-part interview, Dr. Frederickson discusses five key steps to identify and address patient conditions that pose a greater risk of respiratory depression. For readers that have yet to listen to the podcast, please click here; it’s an insightful interview relevant for any clinician working in quality improvement or directly with patients prescribed opioids.
In part two, interviewer Pat Iyer and Dr. Frederickson switches gears and focuses on monitoring issues associated with caring for at-risk patients. You can watch/listen to the interview below: Continue reading “5 Strategies to Keep Patients Safe When Receiving Opioids”
This week’s must reads brings forth key resources relevant to our latest podcast, as well as stories from around the web related to alarm fatigue, patient safety data collection, and opioid guidelines. Continue reading “Patient Safety Weekly Must Reads (September 23, 2016)”
In a recent interview with a spotlight on the RADEO guide, Dr. Thomas Frederickson, MD, FACP, SFHM, MBA highlighted obstructive sleep apnea (OSA) as a key contributing condition to greater opioid use risk.
“Sleep apnea is the number one risk factor for respiratory depression associated with the use of opioids.
[…] Patients with obstructive sleep apnea are dependent upon their arousal mechanism in order to avoid respiratory depression and eventual respiratory failure.”
In addition to being the #1 contributing risk to opioid-induced respiratory depression, OSA is also common and often under diagnosed. Dr. Frederickson states that between 7% and 22% of the adult population has a degree of sleep apnea.
The key question that arises, then, is how to better identify and account for OSA in patients receiving opioids? Here are 5 key resources to reduce the risk of respiratory compromise in this group. Continue reading “5 Key Resources to Reduce the Risk of Respiratory Compromise with Patients with Sleep Apnea”